Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Aging is a natural process characterized by progressive functional impairment and reduced capacity to respond appropriately to environmental stimuli and injury. The incidence of two common chronic respiratory diseases (chronic obstructive pulmonary disease [COPD] and idiopathic pulmonary fibrosis [IPF]) increases with advanced age. It is plausible, therefore, that abnormal regulation of the mechanisms of normal aging may contribute to the pathobiology of both COPD and IPF. This review discusses the available evidence supporting a number of aging mechanisms, including oxidative stress, telomere length regulation, cellular and immunosenescence, as well as changes in a number of antiaging molecules and the extracellular matrix, which are abnormal in COPD and/or IPF. A better understanding of these abnormalities may help in the design of novel and better therapeutic interventions for these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Converging evidence suggests that the aging hallmark, cellular senescence, may be a central mechanism contributing to IPF [6,7].”
From Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study (2019) · cites this paper as [6]
In the citing paper
“IPF pathophysiology is characterized by exaggerated manifestations of the hallmarks of aging in alveolar epithelium and fibroblasts, including cellular senescence.4, 5, 6”
In the citing paper
“A growing body of evidence implicates accelerated mechanisms of ageing, including cellular senescence, in IPF pathogenesis11.”
From Cellular senescence mediates fibrotic pulmonary disease (2017) · cites this paper as [11]
In the citing paper
“cellular senescence has been linked to the pathogenesis of chronic lung diseases such as chronic obstructive pulmonary disease [14, 15] or IPF [16–20].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [14]
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Understanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Cited by
Items 201–267 of 267
Chronic Lung Pathologies That Require Repair and Regeneration
de Hilster, R. H. J., Li, M., Timens, W., Hylkema, M. N., & Burgess, J. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-29403-8_1 · Cited by 4
Shortened Telomere Length is Associated with Adverse Outcomes in COVID-19 Disease
(2021) · Journal of Community Medicine and Public Health Reports · doi:10.38207/jcmphr20210070 · Cited by 2
The Syndrome of Combined Pulmonary Fibrosis and Emphysema
Cottin, V., & Cordier, J.-F. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2401-6_22 · Cited by 4
Castrejón-Vázquez, M. I., Galicia-Tapia, J., Bayardo, R. G., Ortiz-Contreras, F., Cicero-Sabido, R. J., & Vargas-Camaño, M. E. (2014) · Revista Alergia México · doi:10.29262/ram.v61i4.5 · Cited by 3
Comparative Biology of the Normal Lung Extracellular Matrix
Matthes, S. A., Hadley, R. J., Roman, J., & White, E. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-404577-4.00020-5 · Cited by 5
Unraveling the complexity of chronic diseases: an introductory exploration
Prajapati, C., Singh, P., Nand, S., & Singh, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00005-7 · Cited by 4
Metalloproteinases as biomarkers of chronic obstructive pulmonary disease progression
Oa, T., Олеговна, В. О., Евгеньевна, Б. О., & Dubinin, A. O. (2022) · PULMONOLOGIYA · doi:10.18093/0869-0189-2022-2354 · Cited by 2
Diagnosis and treatment of Combined Pulmonary Fibrosis and Emphysema (CPFE)
Wesnawa, M. A. D. P. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.18.3.1147 · Cited by 2
“(27)The effect of smoking which induces oxidative damage can interfere with the potential regeneration of the lung precursor cell compartment, such as precursor mesenchymal cells in emphysema and alveolar epithelial precursors in pulmonary fibrosis.(25,27)”
BackgroundHospitalisation patterns for respiratory diseases in Australia: an ecological study
Rajeh, A. M. A., Naser, A. Y., Aldabayan, Y. S., Alqahtani, J. S., Aldhahir, A. M., Siraj, R. A., Elmosaad, Y. M., Imam, M. H. A., Alghamdi, S. M., & Haykan, A. A. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084286 · Cited by 2
Ishii, T., Gemma, A., & Kida, K. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12354 · Cited by 2
Kanazawa, H., Kyoh, S., Tochino, Y., Asai, K., & Hirata, K. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.02.001 · Cited by 3
“Collagen and elastin are the main proteins in the extracellular matrix that make up the framework of the lung parenchyma and most important in determining the mechanical properties [30].”
BackgroundAging and Chronic Respiratory Diseases: Novel Mechanisms
Sellarés, J., & Rojas, M. (2017) · Barcelona Respiratory Network · doi:10.24875/brn.m17000003 · Cited by 2
Self-citationInterstitial Lung Disease in the Elderly: A Review of Pathogenesis and Clinical Management
Patterson, K. C. (2018) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000270 · Cited by 2
Current mechanisms in the pathogenesis of lung fibrosis
Engin, M. M. N., & Özdemır, Ö. (2023) · Trends in Immunotherapy · doi:10.24294/ti.v7.i1.2028 · Cited by 2
Remodeling of the Extracellular Matrix in the Aging Lung
Roman, J. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch11 · Cited by 4
ANT1 and the SASP: Beyond the Bioenergetic Void
Rangarajan, S. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0264ed · Cited by 2
Oxidative Stress in Obstructive and Restrictive Lung Diseases
Bargagli, E., & Carleo, A. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_9 · Cited by 1
Telomere Shortening in Interstitial Lung Disease: Challenges and Promises
Jin, H., Song, J., Gao, R., Sha, B., Wang, S., Luo, P., Yu, L., Xu, X., & Wang, X. (2025) · The Clinical Respiratory Journal · doi:10.1111/crj.70103 · Cited by 1
Zhang, Y., Zhou, L., Li, Y., Wang, W., Yang, T., Zhang, Q., Tang, H., Guo, J., Huang, L., Wang, C., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.175421 · Cited by 2
The role of telomere shortening in the development and progression of COPD
Amiri, H. M., Cooper, J. P., & NUGENT, K. M. (2013) · The Southwest Respiratory and Critical Care Chronicles · doi:10.12746/swrccc.v1i3.79 · Cited by 1
Fernandez, I. E., & Eickelberg, O. (2012) · Cited by 1
Molecular Mechanisms of Pulmonary Fibrosis
冯, 爱. (2018) · Advances in Clinical Medicine · doi:10.12677/acm.2018.82017 · Cited by 1
“氧化应激是指过多的活性氧(ROS)和/或抗氧化防御系统耗尽,造成分子、细胞和组织异常[46] [47] [48]。相对于其他器官而言,肺更容易受到氧化应激的影响,因为肺内氧分压为体内最高,吸入空气的氧 分压为 150 mmHg,肺泡内的氧分压为 100 mmHg,而静脉血或者其他其器官的氧分压为 1~45 mmHg 之 间。生物系统不断地暴露在外部因素(如:烟草、石棉/二氧化硅、辐射、博来霉素和其他药物等),以及 由炎性细胞以及组织上皮细胞、间质细胞和内皮细胞产生内在因素[49]。体内常见的 ROS 包括:超氧离”
张, 丽. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.123272 · Cited by 1
Peripheral Immune Cell Profiling Reveals Distinct Immune Hallmarks in Progressive Pulmonary Fibrosis
Hernández‐González, F., Mendoza, N., Casas-Recasens, S., Cruz, T., Albacar, N., López-Saiz, G., Alsina‐Restoy, X., Rojas, M. M., Agustí, A. G. N., Sellarés, J., et al. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.06.009 · Cited by 1
Self-citationAirflow obstruction, cognitive function and mortality in a US national cohort: NHANES‐III
Odeyemi, Y., Meda, E., Ogundipe, F., Russ, E., Mehari, A., Obisesan, T. O., & Gillum, R. F. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12643 · Cited by 1
“Although the inhalation of noxious particles and gases, mostly through tobacco smoking, is the main risk factor for airflow obstruction, it is also characterized by abnormal lung ageing.(2) Airflow obstruction is frequently present with one or more comorbidities.”
BackgroundOld Cells in Young Airway Smooth Muscle: Does Neonatal Senescence Cause Lifelong Airway Obstruction?
Sasse, S. K., & Gerber, A. N. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0399ed · Cited by 1
Ahmed, T., Zulfiqar, A., & Ishaq, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-3552-9_3 · Cited by 2
Lung aging and senescence in health and disease
Hernández‐González, F., Saito, N., Agustí, A. G. N., Sellarés, J., & Faner, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00002-x · Cited by 2
Self-citationAging Mesenchymal Stem Cells in Lung Disease
Kapetanaki, M. G., Mora, A. L., & Rojas, M. M. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch12 · Cited by 1
Self-citationOxidative stress and antioxidant imbalance: respiratory disorders
Jindal, S. K. (2016) · Wiley eBooks · doi:10.1002/9781118832431.ch18 · Cited by 1
Tabaco y alteraciones intersticiales: ¿una asociación plausible?
Albacar, N., Faner, R., & Sellarés, J. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.09.006 · Cited by 1
Self-citationSmoking and Interstitial Lung Damage/Effects: A Plausible Association?
Albacar, N., Faner, R., & Sellarés, J. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.09.014 · Cited by 1
Self-citationKızılırmak, D., Karadoğan, D., Yıldırım, H., Akyıl, F. T., Eyüboğlu, T. Ş., Emiralioğlu, N., Sertçelik, Ü. Ö., Günaydın, F. E., Ataoğlu, Ö., Oguz, M. S., et al. (2022) · Turkish Thoracic Journal · doi:10.5152/turkthoracj.2022.21081 · Cited by 1
Pathogenesis of Pulmonary Hypertension
Mathew, R. (2013) · InTech eBooks · doi:10.5772/56179 · Cited by 1
Cor pulmonale crónico como forma de presentación de fibrosis pulmonar: a propósito de un caso
García, G. M., Alonso, D. P., & Montero, H. R. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Bone imaging and strength in chronic obstructive pulmonary disease
Romme, E. A. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140220er
Why a smoker-aging lung develops IPF and not COPD?
Selman, M., & Pardo, A. (2015) · Monografías de Archivos de Bronconeumología
Idiopathic Pulmonary Fibrosis: Treatment Strategies
Varela, B. E., & Tabaj, G. C. (2015) · Clinical Anti-Inflammatory & Anti-Allergy Drugs · doi:10.2174/221270380102150520112938
Cruz, T. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Aging and idiopathic pulmonary fibrosis
Bueno, M., Mora, A. L., & Rojas, M. M. (2015) · doi:10.2217/fmeb2013.13.225
Self-citationAspectos clínicos e genéticos de pacientes brasileiros com Pneumonia Intersticial Familiar
Hortense, A. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-084314
The ageing extracellular matrix of the lung
Boekema, P. H. (2017)
A General Outlook at the Pathogenesis of COPD
Benito, M. (2019) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2019.03.000708
Boysen, M. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Environmental and Occupational agents and Cancer Drug-Induced Oxidative Stress in Pulmonary Fibrosis
Chakraborti, T., Sarkar, J., Pramanik, P. K., & Chakraborti, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_12
Morphological and functional studies in a sheep model of pulmonary fibrosis
Dewage, V., & Nimanthi, S. (2020) · Minerva Access (University of Melbourne)
Bryant, A. J. (2015) · Respiratory medicine · doi:10.1007/978-3-319-23998-9_6
Breyer, M. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131003mb
Schumacher, B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734825206.793563347
Breathing-induced forces influence lung cell fate
Yang, M.-C., Rea-Moreno, M., & Chen, Y. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.004
Wei, L. I., Zhao, X., Wang, M., Wang, H., Rongyu, L. I., & Guoguang, W. A. N. G. (2025) · Research Square · doi:10.21203/rs.3.rs-7015361/v1
The Research Progress of FGF23 and Klotho in Chronic Obstructive Pulmonary Disease
张, 妮. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131112
Lai, X., Huang, S., Lin, S., Pu, L., Wang, Y., Lin, Y., Huang, W., & Wang, Z. (2022) · Figshare · doi:10.6084/m9.figshare.18132433
Yi, C., Liu, J., Deng, W., Luo, C., Qi, J., Chen, M., & Xu, H. (2023) · Figshare · doi:10.6084/m9.figshare.22604159
Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases
Liu, R.-M., & Nakamya, M. F. (2026) · Cells · doi:10.3390/cells15060551 · Cited by 1
Évaluation de la sénescence endothéliale et leucocytaire dans le choc septique
Merdji, H. (2021) · theses.fr (ABES) · doi:10.70675/cbfec802z6c0dz4e06z9276zd4a44c11c814
Immunosenescence in Idiopathic Pulmonary Fibrosis
Xiao, S., Li, Z., Zhang, H., Cai, W., Yu, S., & Song, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s586167
“29 Among these, the decline in CD8+ T cells is most pronounced.”
Cellular Senescence and Premature Aging in Lung Diseases
Aoshiba, K., Tsuji, T., Yamaguchi, K., Itoh, M., & Nakamura, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00017-4
Breyer, M. (2013)
Metadata
- Authors
- Faner, R., Rojas, M., MacNee, W., & Agustí, A.
- Affiliations
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- University of Pittsburgh (US)
- The Queen's Medical Research Institute (GB)
- Corresponding author
- Agustí, Alvar
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08
- Volume
- 186
- Issue
- 4
- Pages
- 306-313
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2160689761
- Cited by
- 268
- References
- 111
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 22 · 2022: 18 · 2021: 28 · 2020: 17 · 2019: 26 · 2018: 21 · 2017: 18 · 2016: 15 · 2015: 26 · 2014: 24 · 2013: 26 · 2012: 5
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- lung aging, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, oxidative stress, telomere length, cellular senescence, immunosenescence, extracellular matrix, aging mechanisms
- MeSH terms
- Aging, Humans, Inflammation, Lung, Oxidative Stress, Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.